Cargando…

P53 mutations in gastric carcinomas.

We carried out an immunohistochemical study and DNA analysis of 30 gastric carcinomas to evaluate p53 overexpression and allelic loss at 17p. The immunohistochemical study demonstrated immunoreactivity for p53 protein in four cases. Allelic loss for the pYNZ22.1 marker was detected in nine cases. In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seruca, R., David, L., Holm, R., Nesland, J. M., Fangan, B. M., Castedo, S., Sobrinho-Simões, M., Børresen, A. L.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1992
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977375/ https://www.ncbi.nlm.nih.gov/pubmed/1586599

Ejemplares similares

TP53 gene mutations and protein accumulation in primary vaginal carcinomas.
por: Skomedal, H., et al.
Publicado: (1995)

Prognostic significance of TP53 alterations in breast carcinoma.
por: Andersen, T. I., et al.
Publicado: (1993)

TP53 allele loss, mutations and expression in malignant melanoma.
por: Flørenes, V. A., et al.
Publicado: (1994)

Retinoblastoma gene structure and product expression in human gastric carcinomas.
por: Constância, M., et al.
Publicado: (1994)

Mutations in the TP53 gene and protein expression of p53, MDM 2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus load.
por: Helland, A., et al.
Publicado: (1998)

TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival
por: Kringen, Pedro, et al.
Publicado: (2005)

TP53 mutations in early-stage ovarian carcinoma, relation to long-term survival
por: Wang, Y, et al.
Publicado: (2004)

Prognostic factors in gastric carcinoma.
por: Carneiro, F., et al.
Publicado: (1997)

Gene expression profiles and the TP53 mutation status are powerful prognostic markers of breast cancer
por: Langerød, A, et al.
Publicado: (2005)

HER-2 activation and TP53 inactivation as predictors of survival in breast cancer
por: Andersen, TI, et al.
Publicado: (2000)

TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer
por: Langerød, Anita, et al.
Publicado: (2007)

Detection of p53 mutations in precancerous gastric tissue
por: Morgan, C, et al.
Publicado: (2003)

Expression of full-length p53 and its isoform Δp53 in breast carcinomas in relation to mutation status and clinical parameters
por: Baumbusch, Lars O, et al.
Publicado: (2006)

Expression of wild-type and mutated TP53 in breast carcinomas
por: Baumbusch, LO, et al.
Publicado: (2005)

Prognostic significance of p53 overexpression in gastric and colorectal carcinoma.
por: Starzynska, T., et al.
Publicado: (1992)

Characterization of extracellular matrix composition in breast carcinoma
por: Bergamaschi, A, et al.
Publicado: (2005)

Absence of p21 expression is associated with abnormal p53 in human breast carcinomas.
por: Ellis, P. A., et al.
Publicado: (1997)

E-Cadherin Destabilization Accounts for the Pathogenicity of Missense Mutations in Hereditary Diffuse Gastric Cancer
por: Simões-Correia, Joana, et al.
Publicado: (2012)

Mutation analysis of P73 and TP53 in Merkel cell carcinoma
por: Gele, M Van, et al.
Publicado: (2000)

Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients
por: Langerød, A, et al.
Publicado: (2000)

p53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma.
por: Mineta, H., et al.
Publicado: (1998)

Amplification and protein over-expression of the neu/HER-2/c-erbB-2 protooncogene in human breast carcinomas: relationship to loss of gene sequences on chromosome 17, family history and prognosis.
por: Børresen, A. L., et al.
Publicado: (1990)

Prediction of TP53 mutations by p53 immunohistochemistry and their prognostic significance in gastric cancer
por: Hwang, Hye Jung, et al.
Publicado: (2020)

p53 polymorphisms associated with mutations in and loss of heterozygosity of the p53 gene in male oral squamous cell carcinomas in Taiwan
por: Hsieh, L-L, et al.
Publicado: (2005)

p53 protein overexpression and allele loss of p53 gene in gastric adenocarcinoma.
por: Choi, S. W., et al.
Publicado: (1994)

Expression of p15(INK4b) and p57(KIP2) and Relationship with Clinicopathological Features and Prognosis in Patients with Vulvar Squamous Cell Carcinoma
por: Holm, Ruth, et al.
Publicado: (2013)

Proliferation and survival molecules implicated in the inhibition of BRAF pathway in thyroid cancer cells harbouring different genetic mutations
por: Preto, Ana, et al.
Publicado: (2009)

Mutation of the TP53 gene and allelic imbalance at chromosome 17p13 in ductal carcinoma in situ.
por: Munn, K. E., et al.
Publicado: (1996)

Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma
por: Köbel, Martin, et al.
Publicado: (2016)

Therapy effect of either paclitaxel or cyclophosphamide combination treatment in patients with epithelial ovarian cancer and relation to TP53 gene status.
por: Smith-Sørensen, B., et al.
Publicado: (1998)

Cribriform-morular variant of thyroid carcinoma
por: Cameselle-Teijeiro, J.M., et al.
Publicado: (2019)

Association between cyclo-oxygenase-2 overexpression and missense p53 mutations in gastric cancer
por: Leung, W K, et al.
Publicado: (2001)

Cas9 activates the p53 pathway and selects for p53-inactivating mutations
por: Enache, Oana M., et al.
Publicado: (2020)

Mutations in p53, p53 protein overexpression and breast cancer survival
por: Rossner, Pavel, et al.
Publicado: (2009)

Overexpression of p53 mRNA in colorectal cancer and its relationship to p53 gene mutation.
por: el-Mahdani, N., et al.
Publicado: (1997)

High prevalence of mutations at codon 249 of the p53 gene in hepatocellular carcinomas from Senegal.
por: Coursaget, P., et al.
Publicado: (1993)

Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas.
por: Dix, B., et al.
Publicado: (1994)

Potential tumorigenic programs associated with TP53 mutation status reveal role of VEGF pathway
por: Joshi, H, et al.
Publicado: (2012)

Mutation of the p53 gene precedes aneuploid clonal divergence in colorectal carcinoma.
por: Carder, P. J., et al.
Publicado: (1995)

Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies
por: Moch, C, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_s7ibrpqr19ivgt8bo97687l872